Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Silk Road Medical Inc (SILK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
10/04/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 SC 13G/A ALLIANCEBERNSTEIN L.P. reports a
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 8-K Quarterly results
07/11/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/12/2023 RW Form RW - Registration Withdrawal Request:
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 SC 13G/A WASATCH ADVISORS LP reports a 10.6% stake in Silk Road Medical Inc.
05/09/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Silk Road Medical Reports First Quarter 2023 Financial Results"
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDED AND RESTATED BYLAWS OF SILK ROAD MEDICAL, INC. 1"
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook"
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.3% stake in Silk Road Medical Inc.
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
10/21/2022 8-K Quarterly results
10/20/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/18/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/17/2022 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/26/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/31/2022 SD Form SD - Specialized disclosure report:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy